Nectar Lifesciences has informed that it enclosed Newspaper Publication in respect of transfer of Equity Shares of the Company against which dividend remain unpaid/unclaimed for 7 conservative years, to Investor Education and Protection Fund (IEPF) pursuant to Rule 6 of the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, which have been published in the newspapers: Business Standard (English-all editions) and Desh Sewak (Punjabi) both dated 19.07.2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1678.50 |
| Dr. Reddys Lab | 1223.50 |
| Cipla | 1229.65 |
| Zydus Lifesciences | 935.65 |
| Lupin | 2302.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: